Occuity

24/07/2025

We're proud to share that Occuity has been recognised as part of a landmark £6 billion UK-India trade announcement, highlighting our recent collaboration with leading Indian medtech company Remidio.

Our partnership is focused on expanding access to our innovative eye health technologies — including the PM1 Pachymeter and upcoming AX1 Axiometer™ — in one of the world’s fastest-growing healthcare markets.

This recognition reinforces our mission to improve access to high-quality, non-invasive diagnostics worldwide, starting with India.

Occuity Recognised in Landmark £6 billion UK-India Trade Announcement

11/06/2025

💬 How much does myopia management cost in the UK & Ireland? We're building a clearer picture. If you offer myopia treatments, take 2 minutes to share your pricing insight.



https://zurl.co/4OEXQ

13/02/2025

💡 China has reclassified Red Light Therapy for myopia, meaning existing treatments are no longer approved.

But what does this mean for RLRL therapy? 🌍👓

How will this impact impact global myopia treatment options? Our latest blog explores what’s really happening.

📖 Read the full article here: https://zurl.co/Hh6hA

💬 If you're an ECP - What do you think? Should red light therapy face tighter scrutiny or wider acceptance? Let us know your thoughts...Join the conversation below! ⬇️

As pointed out many times on this and other websites, myopia is an increasingly common global health issue. Although therapies exist to slow the progression of myopia, there is a large growing body of evidence showing a huge rise in the prevalence of the condition. The visual prognosis for many high...

27/01/2025

Exciting news! 🎉 Occuity is delighted to announce our partnership with Abioz Technologies as our exclusive distributor in France. This collaboration marks a significant step in making our innovative non-invasive optical technologies more accessible across Europe. 🌍

Read more here: https://zurl.co/OQWnk

19/12/2024

ANNOUNCEMENT

If you have been following our journey, you might want to know that Occuity is closing it's current investment round tomorrow - Friday, 20th December 2024. If you wish to take advantage of investing in this round before it closes, please visit https://zurl.co/3CMR5 .

- The minimum investment is £5,016 (209 Shares).
- Before you complete the application form, please ensure you have completed the HNW/Sophisticated Investor Self-certification, and Investor Verification within the last 12 months - (click here).

If you have any problems with these or have any questions, please email marketing@occuity.com

11/12/2024

🚀 Exciting News from Occuity!
We’re proud to announce Von Hoff as our exclusive distributor for the PM1 Pachymeter and AX1 Axiometer in Switzerland and Liechtenstein. With CE certification now achieved, the PM1 brings revolutionary non-contact technology to glaucoma screening and corneal diagnostics.

Mark Jenkins, COO of Occuity, said: "Partnering with Von Hoff is fantastic news. Their expertise and commitment to innovation will be instrumental in bringing our products to clinicians and patients across the region."

👉 Read the full announcement here https://zurl.co/ITQTy

Occuity, a UK-based leader in non-contact handheld medical devices, is pleased to announce the appointment of Von Hoff as the exclusive distribution partner for its ophthalmic product line, including the PM1 Pachymeter and AX1 Axiometer, in Switzerland and Liechtenstein. This partnership marks anoth...

13/11/2024

🌟 Lighting Up Occuity! 🌟

We recently celebrated Diwali, the Festival of Lights, at Occuity with decorations, traditional Indian treats, and plenty of laughter! 🎉 Our multicultural team, with members from the UK, Iran, Egypt, India, and across Europe, embraced this beautiful occasion together, enjoying a vibrant spread of pani puri, kaju katli, and jalebi. 🥘✨

Celebrating diverse traditions like Diwali brings us closer, sparks new conversations, and reminds us of the joy of working together. Read our latest blog to see how we light up our workplace culture.

https://zurl.co/ZPsw

Diwali, also known as the Festival of Lights, is one of the most significant festivals in India, celebrated by millions of people around the world. It symbolises the victory of light over darkness and good over evil, commemorating the return of Lord Rama to his kingdom after defeating the demon king...

04/11/2024

In this video, Optometrist, Jason Higginbotham, introduces the PM1 Pachymeter, the world's first handheld, non-contact optical pachymeter. Jason demonstrates what is included with the device, how to set it up and how to take corneal centre thickness (CCT) measurements quickly and effectively. He provides some best practice advice and offers some hints and tips.

https://zurl.co/hY6O

Please Note:
This video is intended for information purposes only. We advise you to read the PM1's 'Instructions For Use' manual before operating the device.

In this video, Optometrist, Jason Higginbotham, introduces the PM1 Pachymeter, the world's first handheld, non-contact optical pachymeter. Jason demonstrates...

01/10/2024

👀 *BREAKING NEWS* 👀

We are delighted to announce that the PM1 Pachymeter has secured CE Marking! This achievement marks a significant milestone, paving the way for the launch of our non-contact handheld device, designed to assist clinicians in diagnosing glaucoma with precision and ease.

The PM1 represents a breakthrough in eye care, providing a safer, more comfortable, and faster alternative to traditional methods. By eliminating the need for physical contact, our technology minimises the risk of infection transmission and ensures a more efficient screening process.

This is just the beginning! With CE marking in place, we’re now preparing to bring this innovation to clinicians and patients globally.

Learn more about our revolutionary technology and what’s next! 👉 Link to the full story in the comments.

Occuity secures CE Marking for PM1 Pachymeter: A Major Milestone for the Company

25/09/2024

🚀 Exciting News from Occuity! 🚀
We're delighted to announce our partnership with Skymed Ltd., making them the exclusive distributor of our ophthalmic series of devices starting with the PM1 Pachymeter in Israel.

Tzah Kimchi, Executive Director of Skymed Ltd., shared his thoughts:
"We are thrilled to partner with Occuity to bring their state-of-the-art ophthalmic products to Israel. The PM1 Pachymeter is a remarkable device that will benefit a wide range of clinical settings, from glaucoma and refractive surgery clinics to general ophthalmology."

At Occuity, we’re delighted to announce an exciting new partnership that will extend the reach of our cutting-edge ophthalmic devices. Following a successful showcase at the European Society of Cataract and Refractive Surgeons (ESCRS) congress in Barcelona, we’ve appointed Skymed Ltd. as our exc...

13/09/2024

🏆 Exciting Awards News!🏆

We are absolutely delighted to announce that Occuity has won the *National Medtech & Healthtech StartUp of the Year* award at the UK StartUp Awards! 🎉

After winning the South East regional title, we progressed to the final at Ideas Fest in Tring against eight other brilliant regional winners, and we’re honoured to have been recognised for our innovative approach to health diagnostics.

At Occuity, we’re dedicated to revolutionising healthcare through Oculomics, using the eye as a non-invasive window to diagnose and monitor chronic health conditions such as diabetes and Alzheimer’s Disease. This award is a testament to the incredible potential of our technology, and we’re excited to see how it will transform patient care.

Our CEO Dan Daly and Emily Patterson, one of our Future Leaders Fellows, were proud to accept the award at Ideas Fest.

Dan said: “We believe the eye holds the key to understanding many health conditions. This national recognition is a huge honour, and it reinforces our mission to bring painless, contact-free health monitoring to millions of people worldwide.”

We extend a massive thank you to our great team, the judges, organisers, and all our supporters who have believed in our vision. This is just the beginning, and we’re looking forward to what the future holds as we continue to innovate and expand.

🔗 Learn more about our journey and our ground-breaking work in Oculomics here: https://zurl.co/i4yD

Occuity awarded prestigious title of National Medtech & Healthtech StartUp of the Year at UK StartUp Awards

11/09/2024

Our COO Mark Jenkins and Head of Marketing, Richard Kadri-Langford, have just returned from a fantastic few days at ESCRS 2024 in Barcelona, where we showcased Occuity's ophthalmic devices – including the PM1 Pachymeter and the AX1 Axiometer. ESCRS, attracts such a valuable audience it provides us with the perfect opportunity to connect with distributors from regions like Australia, South East Asia, and Latin America. In just three packed days, they hosted 26 meetings – an invaluable chance to meet so many people in one place.

It wasn’t all work, though – they did have a few hours on their travel days to explore the beautiful city of Barcelona, including a visit to the amazing bucket-list worthy, Sagrada Familia. Whilst the weather was a bit unsettled, not even thunderstorms could stop us or our visitors!

ESCRS remains a key event for us, allowing us to strengthen existing relationships and build new partnerships. We’re excited about the promising discussions we had and look forward to following up in the coming weeks.

We're already looking forward to Copenhagen 2025! See you there!

Read more about our journey here: https://zurl.co/BZAG

Occuity COO, Mark Jenkins and Head of Marketing, Richard Kadri-Langford head to Barcelona to showcase the PM1 and AX1 at ESCRS 2024